Cognitive Dysfunction in Patients With Cancer Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

928 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-08-21

Study Completion Date

2019-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the occurrence of cognitive dysfunction in cancer patients with pain in China.Analysis of patients with different cancer pain, different analgesic drugs and different treatments are associated with the severity of cognitive dysfunction, to provide relevant evidence for the next screening, prediction, prevention and treatment. In order to achieve the purpose of improving the quality of life of cancer patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Vulnerability and Risk of Neuropathic Pain in Cancer

NCT06511674

Neuropathic Pain Cancer Predictive

RECRUITING NA

Cancer Chronic Pain Predicted by Emotional and Cognitive Status

NCT02777697

Chronic Pain Cancer

COMPLETED

Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms

NCT04611620

Survivorship Cognitive Dysfunction Pain +4 more

COMPLETED

Cognitive Changes in Adult Cancer Survivors

NCT01569932

Effects of Chemotherapy Cognitive Impairment

COMPLETED

Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy

NCT01506440

Malignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cross-sectional survey in patients with cancer pain is used in the outpatient clinics and wards of five cancer hospitals in China.

This study is to survey the incidence of cognitive dysfunction in Chinese cancer patients, and the related factors of cognitive dysfunction, demographic characteristics (economic situation, education, gender, age), disease status (tumor type, staging) ), analgesic treatment (NRS score, with or without analgesic drugs, analgesic drug name, dose), anti-tumor treatment (with or without anti-tumor treatment, surgery, radiotherapy, chemotherapy, time interval from last treatment, chemotherapy drugs) and so on.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Malignant tumor patient with pain are confirmed by histopathology or cytology (NRS score ≥ 1);
* Understand Chinese through verbal and written communication, read and write Chinese, numbers, and complete questionnaire surveys;
* Male or female, age 18-75 years old;
* ECOG 0-2, expected to survive for more than 3 months;
* no obvious dysfunction of heart, lung, liver, kidney, blood system (≤I degree);
* patients voluntarily sign informed consent

Exclusion Criteria

* Pregnant women and lactating women.
* Also participate in clinical trials of drugs that have not been approved for marketing.
* Patients with depression (evaluated by the Hamilton Depression Scale).
* Active bleeding or bleeding tendency.
* Serious or uncontrolled medical conditions and infected people.
* Patients with structural heart disease, such as coronary heart disease, unstable angina, especially patients with congestive heart failure and atrial fibrillation, atrial flutter history, and patients with hypertension, hypercoagulable state and severe cerebrovascular disease.
* History of thromboembolic disease; long-term oral administration of aspirin and other anticoagulants.
* Preventive Whole Brain Irradiation (PCI).
* Bone marrow invasion or bone marrow metastasis.
* Patients with severe or uncontrollable mental illness.

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No